Key pointsr Glioma multiforme is a fast expanding and aggressive type of brain tumour that invades healthy brain tissue by migration of single glioma cells along blood vessels.r We show that bradykinin, a neuropeptide of the vasculature, induces the formation of small bleb-like protrusions at the plasma membrane of glioma cells in vitro, which are regulated by intracellular Ca 2+ , resulting in contraction of the cytoskeleton, cytoplasmatic flow and activation of Ca 2+ -dependent K + and Cl − channels.r From our in vitro experiments we conclude that bradykinin facilitates glioma invasion by stimulating an amoeboid phenotype of migration.r In situ experiments confirmed that bradykinin increases the speed of glioma cell migration, which we have been able to block with blebbistatin, an inhibitor of membrane blebbing, and with the B2 receptor agonist Hoe-140.r The study reveals novel mechanisms of bradykinin-induced glioma migration and suggests pharmacological targets to reduce glioma invasion.Abstract The molecular and cellular mechanisms governing cell motility and directed migration in response to the neuropeptide bradykinin are largely unknown. Here, we demonstrate that human glioma cells whose migration is guided by bradykinin generate bleb-like protrusions. We found that activation of the B2 receptor leads to a rise in free Ca 2+ from internal stores that activates actomyosin contraction and subsequent cytoplasmic flow into protrusions forming membrane blebs. Furthermore Ca 2+ activates Ca 2+ -dependent K + and Cl − channels, which participate in bleb regulation. Treatment of gliomas with bradykinin in situ increased glioma growth by increasing the speed of cell migration at the periphery of the tumour mass. To test if bleb formation is related to bradykinin-promoted glioma invasion we blocked glioma migration with blebbistatin, a blocker of myosin kinase II, which is necessary for proper bleb retraction. Our findings suggest a pivotal role of bradykinin during glioma invasion by stimulating amoeboid migration of glioma cells.